• Profile
Close

The association between autoimmune disease and 30-day mortality among sepsis ICU patients: A cohort study

Critical Care Mar 22, 2019

Sheth M, et al. - Researchers used the Multiparameter Intelligent Monitoring in Intensive Care III database (v. 1.4) to compare outcomes—especially 30-day mortality risk—between sepsis patients with autoimmune diseases and sepsis patients without these comorbidities. Known confounders, including demographics, disease severity, and immunomodulation medications were controlled via logistic regression models. They also assessed the impact of chronic use of immunomodulation medications on the link between autoimmune disease and 30-day mortality in mediation analysis. Findings revealed a lower 30-day mortality risk in sepsis in relation to autoimmune diseases. A mechanism that was not related to the chronic use of immunomodulation medications was responsible for the observed impact of autoimmune diseases on 30-day mortality.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay